An estimated 8250 new cases of testicular cancer will be diagnosed in the United States in 2006, with germ cell tumors (GCTs) constituting 95% of the malignant tumors arising in the testes. Although GCTs are relatively uncommon tumors, they are the most common solid tumor in men between the ages of 15 and 34 years. The worldwide incidence of these tumors has more than doubled in the past 40 years. More than 90% of all patients diagnosed with GCTs are cured, including 70% to 80% of patients with advanced tumors who are treated with chemotherapy. Standard therapy has been established at essentially all stages of management and must be closely followed to ensure the potential for cure.
For the most recent version of the guidelines, please visit NCCN.org
If the inline PDF is not rendering correctly, you can download the PDF file here.
The University of Nebraska Medical Center (UNMC) Eppley Cancer Center (www.unmc.edu/cancercenter) is a partnership of UNMC, the Eppley Institute for Cancer, and The Nebraska Medical Center.
The Center integrates research and education with patient care to offer the most up-to-date treatments for a variety of cancers. This unique collaboration between The Nebraska Medical Center cancer physicians and UNMC researchers allows discoveries made in the laboratories to be taken directly to the patient.
A National Cancer Institute-designated Clinical Cancer Center and founding member of the National Comprehensive Cancer Network (NCCN), the Center has extensive interdisciplinary research and therapy programs in lymphoma, stem cell transplantation, gastrointestinal and pancreatic cancer, prostate cancer, breast cancer, and aerodigestive cancers.
Center Director Kenneth H. Cowan, MD, PhD (second photo on cover), is a leading breast cancer clinician and researcher. He joined the Center in 1999 after 21 years with the National Cancer Institute.